Tafinlar 75mg Capsules available in Pakistan contain Dabrafenib, a targeted oncology medication indicated for the treatment of patients with melanoma, non-small cell lung cancer (NSCLC), and thyroid cancer exhibiting a specific BRAF V600E or V600K gene mutation. Produced by Novartis Pharmaceuticals, Tafinlar functions by inhibiting the abnormal BRAF proteins responsible for cancer cell proliferation, thereby decelerating or halting tumor advancement.
- Effective targeted therapy for BRAF V600 mutation-positive malignancies
- Treats advanced melanoma, lung, and thyroid cancers
- Slows or halts cancer cell proliferation
- Can be administered alone or in conjunction with Mekinist (Trametinib) for enhanced efficacy
- Improves survival rates and mitigates tumor progression
- Oral administration – convenient and non-invasive
- FDA-approved and clinically validated
- Manufactured by Novartis, a globally recognized pharmaceutical leader
Dosage: Typically 150mg daily (two 75mg capsules), administered twice daily (morning and evening) approximately 12 hours apart. Administration: Consume on an empty stomach (1 hour prior to or 2 hours following a meal). Precaution: Do not crush, chew, or open the capsules. Note: Adhere to the prescribed regimen, even if feeling well. Combination Therapy: Commonly utilized with Mekinist (Trametinib) under medical supervision.
Active Ingredient: Dabrafenib Mesylate equivalent to Dabrafenib 75mg
Inactive Ingredients: Magnesium stearate, microcrystalline cellulose, colloidal silicon dioxide, hypromellose, titanium dioxide, and iron oxide (colorant).
WellnessOne Liquid Copper Supplements - Mineral Ultra Concentrate In Pakistan
Rs : 4500 Rs : 3450 - 23% Off
Customers Reviews For Tafinlar 75mg Capsule In Pakistan